You have 9 free searches left this month | for more free features.

City

Moscow (1)

Saint Petersburg (1)

Condition

Ankylosing Spondylitis (1)

COVID-19 (1)

Mild to Moderate (1)

Moderate to Severe Plaque Psoriasis (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Biocad (2)

Pirogov Russian National Research Medical University (1)

Collaborator

City Clinical Hospital No.52 of Moscow Healthcare Department (1)

Intervention

placebo (2)

baricitinib oral tablet (1)

bcd-085 (1)

bcd-085 q2w (1)

bcd-085 q4w (1)

netakimab (1)

standard of care therapy (1)

tocilizumab injection (1)

Study Documents

Intervention Type

drug (3)

other (2)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

netakimab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Russian Clinical and Research Center of Gerontology of Pirogov

Completed

COVID-19
Mild to Moderate

Baricitinib Oral Tablet
+3 more

Moscow, Russian Federation
+1 more

Mar 31, 2022

Ankylosing Spondylitis Trial (BCD-085, Placebo)

Completed

Ankylosing Spondylitis

BCD-085
Placebo

(no location specified)

Oct 25, 2021

Moderate to Severe Plaque Psoriasis Trial in Saint Petersburg (BCD-085 Q2W, BCD-085 Q4W, Placebo)

Completed

Has Results

Moderate to Severe Plaque Psoriasis

BCD-085 Q2W
+2 more

Saint Petersburg, Strelna, Russian Federation

BIOCAD

May 11, 2022